Homocysteine and hydroxyproline levels in patients with primary open-angle glaucoma

Current Eye Research

Volumn 37, Issue 8, 2012, Pages 712-718

  Ghanem, Asaad A ^a   Mady, Salah M ^b   El Awady, Hatem E ^a   Arafa, Lamiaa F ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b BENHA UNIVERSITY   (Egypt)

Author keywords

Aqueous humor; Cataract; Homocysteine; Hydroxyproline; POAG

Indexed keywords

HOMOCYSTEINE; HYDROXYPROLINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AQUEOUS HUMOR; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PARACENTESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENILE CATARACT; SPECTROMETRY; VISUAL FIELD DEFECT;

AGED; AQUEOUS HUMOR; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLIC ACID; GLAUCOMA, OPEN-ANGLE; HOMOCYSTEINE; HUMANS; HYDROXYPROLINE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPECTRUM ANALYSIS; VITAMIN B 12; VITAMIN B 6;

EID: 84863709498     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.669512     Document Type: Article

References (34)

1. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37:3483-3493.
2. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res. 2001;64:523-532.
3. Fuchsjager-Mayrl G, Wally B, Georgopoulos M et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004;45:834-839.
4. Moore P, El-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB. Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001;73:45-57.
5. Carroll JF, Tyagi SC. Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens. 2005;18:692-698.
6. Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res. 2010;35:295-301.
7. Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775-1781.
8. Vine AK, Stader J, Branham K, Musch DC, Swaroop A. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology. 2005;112:2076-2080.
9. Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588-1592.
10. Marcucci R, Bertini L, Giusti B et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost. 2001;86:772-776.
11. Bleich S, Roedl J, Von Ahsen N et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.
12. Refsum H, Smith AD, Ueland PM et al. Facts and recommendations about total homocysteine determinations: An expert opinion. Clin Chem. 2004;50:3-32.
13. Wang G, Medeiros FA, Barshop BA, Weinreb RN. Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol. 2004;137:401-406.
14. Clarke R, Stansbie D. Assessment of homocysteine as a cardiovascular risk factor in clinical practice. Ann Clin Biochem. 2001;38:624-632.
15. Pihlajaniemi T, Myllyla R, Kivirikko KI. Prolyl 4-hydroxylase and its role in collagen synthesis. J Hepatol. 1991;13 Suppl 3:S2-S7.
16. Eroshevskii TI, Sviatkovskaia TIa. [Study of serum hydroxyproline in healthy persons and in patients with primary glaucoma in relation to age]. Oftalmol Zh. 1977;32:101-103.
17. Ozyurt H, Totan A, Sahin S, Kilinc C, Sogut S, Akyol O. Maternal serum and amniotic fluid hydroxyproline levels in neural tube defects. Fetal Diagn Ther. 2003;18:321-323.
18. WOESSNER JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961;93:440-447.
19. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary openangle glaucoma. Arch Ophthalmol. 1997;115:1031-1035.
20. Roedl JB, Bleich S, Reulbach U et al. Homocysteine levels in aqueous humor and plasma of patients with primary openangle glaucoma. J Neural Transm. 2007;114:445-450.
21. Wang G, Medeiros FA, Barshop JM, et al. Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol. 2004;137:401-406.
22. Altintas O, Maral H, Yuksel N, Karabas VL, Dillioglugil MO, Caglar Y. Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:677-683.
23. Turgut B, Kaya M, Arslan S, Demir T, Guler M, Kaya MK. Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin Interv Aging. 2010;5:133-139.
24. Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol. 2006;6:6.
25. Bleich S, Junemann A, von Ahsen N et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm. 2002;109: 1499-1504.
26. Clement CI, Goldberg I, Healey PR, Graham SL. Plasma homocysteine, MTHFR gene mutation, and open-angle glaucoma. J Glaucoma. 2009;18:73-78.
27. Stamler JS, Osborne JA, Jaraki O et al. Adverse vascular effects of homocysteine are modulated by endotheliumderived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
28. Tang L, Mamotte CD, Van Bockxmeer FM, Taylor RR. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle. Atherosclerosis. 1998;136:169-173.
29. Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895-901.
30. Kirwan RP, Leonard MO, Murphy M, Clark AF, O'Brien CJ. Transforming growth factor-β-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Glia. 2005;52:309-324.
31. Kuchle M, Ho TS, Nguyen NX, Hannappel E, Naumann GO. Protein quantification and electrophoresis in aqueous humor of pseudoexfoliation eyes. Invest Ophthalmol Vis Sci. 1994;35:748-752.
32. Morrow JD, Roberts LJ 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Meth Enzymol. 1999;300:3-12.
33. Fukunaga M, Makita N, Roberts LJ 2nd, Morrow JD, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264:C1619-C1624.
34. Lahaie I, Hardy P, Hou X et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 a on retinal vessels. Am J Physiol. 1998;274:R1406-R1416.